Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.
Nat Cell Biol. 2014 Nov;16(11):1069-79. doi: 10.1038/ncb3053. Epub 2014 Oct 19.
Cells rely on autophagy to clear misfolded proteins and damaged organelles to maintain cellular homeostasis. In this study we use the new autophagy inhibitor PIK-III to screen for autophagy substrates. PIK-III is a selective inhibitor of VPS34 that binds a unique hydrophobic pocket not present in related kinases such as PI(3)Kα. PIK-III acutely inhibits autophagy and de novo lipidation of LC3, and leads to the stabilization of autophagy substrates. By performing ubiquitin-affinity proteomics on PIK-III-treated cells we identified substrates including NCOA4, which accumulates in ATG7-deficient cells and co-localizes with autolysosomes. NCOA4 directly binds ferritin heavy chain-1 (FTH1) to target the iron-binding ferritin complex with a relative molecular mass of 450,000 to autolysosomes following starvation or iron depletion. Interestingly, Ncoa4(-/-) mice exhibit a profound accumulation of iron in splenic macrophages, which are critical for the reutilization of iron from engulfed red blood cells. Taken together, the results of this study provide a new mechanism for selective autophagy of ferritin and reveal a previously unappreciated role for autophagy and NCOA4 in the control of iron homeostasis in vivo.
细胞依赖自噬来清除错误折叠的蛋白质和受损的细胞器,以维持细胞内稳态。在这项研究中,我们使用新的自噬抑制剂 PIK-III 来筛选自噬底物。PIK-III 是 VPS34 的选择性抑制剂,它结合了一个独特的疏水性口袋,而在相关激酶(如 PI(3)Kα)中不存在。PIK-III 可急性抑制自噬和 LC3 的从头脂质化,并导致自噬底物的稳定。通过对 PIK-III 处理的细胞进行泛素亲和蛋白质组学分析,我们鉴定了包括 NCOA4 在内的底物,NCOA4 在 ATG7 缺陷细胞中积累,并与自噬溶酶体共定位。NCOA4 直接与铁蛋白重链-1 (FTH1) 结合,将相对分子质量为 450,000 的含铁铁蛋白复合物靶向自噬溶酶体,在饥饿或铁耗竭后。有趣的是,Ncoa4(-/-) 小鼠脾脏巨噬细胞中铁的积累明显增加,而巨噬细胞对从吞噬的红细胞中再利用铁至关重要。总之,这项研究的结果提供了铁蛋白选择性自噬的新机制,并揭示了自噬和 NCOA4 在体内铁稳态控制中的先前未被认识的作用。